These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22729866)
1. ACB-PCR measurement of H-ras codon 61 CAA→CTA mutation provides an early indication of aristolochic acid I carcinogenic effect in tumor target tissues. Wang Y; Arlt VM; Roufosse CA; McKim KL; Myers MB; Phillips DH; Parsons BL Environ Mol Mutagen; 2012 Aug; 53(7):495-504. PubMed ID: 22729866 [TBL] [Abstract][Full Text] [Related]
2. Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and K-Ras mutant fraction. Wang Y; Meng F; Arlt VM; Mei N; Chen T; Parsons BL Mutagenesis; 2011 Sep; 26(5):619-28. PubMed ID: 21642617 [TBL] [Abstract][Full Text] [Related]
3. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Schmeiser HH; Janssen JW; Lyons J; Scherf HR; Pfau W; Buchmann A; Bartram CR; Wiessler M Cancer Res; 1990 Sep; 50(17):5464-9. PubMed ID: 2201437 [TBL] [Abstract][Full Text] [Related]
4. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mei N; Arlt VM; Phillips DH; Heflich RH; Chen T Mutat Res; 2006 Dec; 602(1-2):83-91. PubMed ID: 17010389 [TBL] [Abstract][Full Text] [Related]
5. ACB-PCR measurement of spontaneous and furan-induced H-ras codon 61 CAA to CTA and CAA to AAA mutation in B6C3F1 mouse liver. Banda M; Recio L; Parsons BL Environ Mol Mutagen; 2013 Oct; 54(8):659-67. PubMed ID: 24038307 [TBL] [Abstract][Full Text] [Related]
6. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures. Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154 [TBL] [Abstract][Full Text] [Related]
7. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers. Stiborova M; Frei E; Arlt VM; Schmeiser HH Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519 [TBL] [Abstract][Full Text] [Related]
8. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Arlt VM; Stiborova M; Schmeiser HH Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620 [TBL] [Abstract][Full Text] [Related]
9. Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice. Arlt VM; Zuo J; Trenz K; Roufosse CA; Lord GM; Nortier JL; Schmeiser HH; Hollstein M; Phillips DH Int J Cancer; 2011 Jan; 128(1):21-32. PubMed ID: 20232387 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models. Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney. Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565 [TBL] [Abstract][Full Text] [Related]
12. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene. Arlt VM; Wiessler M; Schmeiser HH Carcinogenesis; 2000 Feb; 21(2):235-42. PubMed ID: 10657963 [TBL] [Abstract][Full Text] [Related]
13. Aristolochic acid I promoted clonal expansion but did not induce hepatocellular carcinoma in adult rats. Liu YZ; Lu HL; Qi XM; Xing GZ; Wang X; Yu P; Liu L; Yang FF; Ding XL; Zhang ZA; Deng ZP; Gong LK; Ren J Acta Pharmacol Sin; 2021 Dec; 42(12):2094-2105. PubMed ID: 33686245 [TBL] [Abstract][Full Text] [Related]
14. Chronic renal failure rats are highly sensitive to aristolochic acids, which are nephrotoxic and carcinogenic agents. Cheng CL; Chen KJ; Shih PH; Lu LY; Hung CF; Lin WC; Yesong Gu J Cancer Lett; 2006 Feb; 232(2):236-42. PubMed ID: 16458120 [TBL] [Abstract][Full Text] [Related]
15. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone. Arlt VM; Meinl W; Florian S; Nagy E; Barta F; Thomann M; Mrizova I; Krais AM; Liu M; Richards M; Mirza A; Kopka K; Phillips DH; Glatt H; Stiborova M; Schmeiser HH Arch Toxicol; 2017 Apr; 91(4):1957-1975. PubMed ID: 27557898 [TBL] [Abstract][Full Text] [Related]
16. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697 [TBL] [Abstract][Full Text] [Related]
17. Mutations induced by carcinogenic doses of aristolochic acid in kidney of Big Blue transgenic rats. Chen L; Mei N; Yao L; Chen T Toxicol Lett; 2006 Sep; 165(3):250-6. PubMed ID: 16764999 [TBL] [Abstract][Full Text] [Related]
18. The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro. Sborchia M; De Prez EG; Antoine MH; Bienfait L; Indra R; Valbuena G; Phillips DH; Nortier JL; Stiborová M; Keun HC; Arlt VM Arch Toxicol; 2019 Nov; 93(11):3345-3366. PubMed ID: 31602497 [TBL] [Abstract][Full Text] [Related]
19. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats. Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820 [TBL] [Abstract][Full Text] [Related]
20. Levels of 4-aminobiphenyl-induced somatic H-ras mutation in mouse liver DNA correlate with potential for liver tumor development. Parsons BL; Beland FA; Von Tungeln LS; Delongchamp RR; Fu PP; Heflich RH Mol Carcinog; 2005 Apr; 42(4):193-201. PubMed ID: 15761837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]